IP Library Granted Patent US 12,048,303
Granted Patent B2
US 12,048,303 · App. 17/253,741 · Granted Jul 30, 2024

Systems and methods to perfuse isolated tissue

Inventors: Bohdan Pomahac (Boston, MA); Maximilian Kückelhaus (Boston, MA)
Assignee: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
A01N1/0247A01N1/021
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,048,303
App. No.
17/253,741
Granted
Jul 30, 2024
Kind
B2
Abstract

Systems and methods to perfuse isolated tissue are provided to avoid ischemia-related tissue damage over an extended perfusion time is provided. A system can comprise a reservoir sized and dimensioned to contain a perfusate. A perfusion supply line can comprise a pump, a cooling system, an oxygenator, and at least one filter. The perfusion supply line can be in fluid communication with the reservoir to draw the perfusate from the reservoir and cool and oxygenate the perfusate. The system can also include an arterial line in fluid communication with the perfusion supply line to direct perfusate from the reservoir to the isolated tissue. A venous outflow can be in fluid communication with the isolated tissue to remove the perfusate from the isolated tissue. A perfusion return line can be in fluid communication with the venous outflow to return the perfusate from the isolated tissue to the reservoir.

Claims (33)

1. A perfusion system to perfuse isolated tissue having a defined arterial inflow comprising:

a reservoir sized and dimensioned to contain a perfusate;

a perfusion supply line comprising a single pump, a cooling system, an oxygenator, and a bacterial filter configured to filter pathogens from the perfusate, the perfusion supply line in fluid communication with the reservoir to draw the perfusate from the reservoir and cool and oxygenate the perfusate;

an arterial line in fluid communication with the perfusion supply line to direct perfusate from the reservoir to the isolated tissue, the bacterial filter being upstream of the arterial line;

wherein the bacterial filter is a first bacterial filter and further comprising:

a first pre-filter positioned upstream of the bacterial filer, the first pre-filter being configured to remove undissolved perfusate articles from the perfusate that have a size of greater than 1 μm;

a second pre-filter fluidly coupled to the pump the second pre-filter being configured to remove undissolved perfusate particles from the perfusate having a size greater than 1 μm; and

a second bacterial filter fluidly coupled to the pump and positioned downstream of the second pre-filter, and

wherein the first pre-filter and the first bacterial filter are positioned upstream of downstream of the oxygenator; and

wherein the second pre-filter and the second bacterial filter are positioned downstream of the oxygenator; and

wherein the single pump draws the perfusate from the reservoir, passes the perfusate first through the first pre-filter and the first bacterial filter, then through the oxygenator, then through the second pre-filter and the second bacterial filter, and then into the arterial line to perfusate the isolate tissue.

2. The perfusion system of claim 1 , further comprising:

a venous outflow in fluid communication with the isolated tissue to remove the perfusate from the isolated tissue; and

a perfusion return line in fluid communication with the venous outflow to return the perfusate from the isolated tissue to the reservoir.

3. The perfusion system of claim 1 , further comprising a control system to direct a cycle of the perfusate from the reservoir, through the perfusion supply line, and through the isolated tissue.

4. The perfusion system of claim 1 , further comprising at least one sensor configured to measure perfusion solution flow rate, perfusate pressure, perfusate temperature, perfusate oxygenation, perfusate composition, or any combination thereof.

5. The perfusion system of claim 4 , wherein the at least one sensor is configurated to measure creatine kinase, Lactate dehydrogenase, myoglobin, lactic add, pH, potassium level, glucose level, calcium level, or combinations thereof.

6. The perfusion system of claim 1 , further comprising a control system in electrical communication with at least one sensor configured to measure a characteristic of the isolated tissue or the perfusion system, the at least one sensor configured to send a sensor signal to the control system in response to the measurement, the control system programmed to send a feedback signal to electronics housed with the perfusion system in response to the sensor signal.

7. The perfusion system of claim 1 , wherein the cooling system comprises a heat exchanger and a cooling reservoir, the cooling reservoir sized and dimensioned to hold water and ice.

8. The perfusion system of claim 1 , wherein the perfusate includes at least two of Albumin, Dextran 40, Glucose, Potassium chloride, Sodium chloride, Calcium chloride, Magnesium chloride, Sodium dihydrogen phosphate, Sodium bicarbonate, Sodium hydroxide, Dextrose, Insulin, Methylprednisone, Calcium chloride dihydrate, Sodium dihydrogen phosphate dihydrate, Magnesium chloride hexahydrate, D(+)-glucose monohydrate, Human Serum Albumin, Sterile water, Citric acid (anhydrous), Sodium citrate (dihydrate), Monobasic Sodium Phosphate (monohydrate; NaH2PO4:H2O), or Dextrose (monohydrate).

9. The perfusion system of claim 3 , further comprising a mobile container housing the reservoir, the perfusion supply line, and electronics in electrical communication with the control system.

10. The perfusion system of claim 1 , further comprising a dissolved oxygen sensor fluidly coupled to the pump; and

a bubble trap fluidly coupled to the pump, the bubble trap being downstream of the bacterial filter.

11. The perfusion system of claim 10 , further comprising:

a chamber configured to receive a limb that is the isolated tissue, the chamber fluidly coupled to the reservoir, via a return line; and

a dissolved carbon dioxide sensor fluidly coupled to the return line.

12. The perfusion system of claim 10 , wherein the reservoir is a perfusate reservoir, and further comprising a cooling circuit that includes:

a first heat exchanger thermally coupled to the perfusate to cool the perfusate;

a cooling reservoir configured to contain a mixture of water and ice; and

a second heat exchanger thermally coupled to the cooling reservoir.

13. The perfusion system of claim 1 , further comprising a heat exchanger thermally coupled to the perfusate; and

wherein the heat exchanger is configured to cool the perfusate to at least 10° C.

14. The perfusion system of claim 1 , wherein the perfusate is acellular.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2024
From: THE GENERAL HOSPITAL CORPORATION
To: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
Reel/Frame 067107/0269 →
CONFIRMATORY LICENSE Recorded Jan 4, 2022
From: BRIGHAM AND WOMEN'S HOSPITAL
To: THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY
Reel/Frame 058541/0307 →
Continuity (1)
Related Publication 20210259241A1 · Aug 26, 2021